Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - Microbot Medical Inc. | f58670e10vk.htm |
| EX-31.2 - EX-31.2 - Microbot Medical Inc. | f58670exv31w2.htm |
| EX-23.1 - EX-23.1 - Microbot Medical Inc. | f58670exv23w1.htm |
| EX-32.2 - EX-32.2 - Microbot Medical Inc. | f58670exv32w2.htm |
| EX-10.34 - EX-10.34 - Microbot Medical Inc. | f58670exv10w34.htm |
| EX-10.35 - EX-10.35 - Microbot Medical Inc. | f58670exv10w35.htm |
| EX-31.1 - EX-31.1 - Microbot Medical Inc. | f58670exv31w1.htm |
Exhibit 32.1
Certification Pursuant to 18 U.S.C. Section 1350, As Adopted Pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002
In connection with the StemCells, Inc. (the “Company”) Annual Report on Form 10-K for the year
ended December 31, 2010 as filed with the Securities and Exchange Commission on the date hereof
(the “Report”), I, Martin McGlynn, President and Chief Executive Officer of the Company, certify
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002, that, to the best of my knowledge:
(1). The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities
Exchange Act of 1934, as amended; and
(2). The information contained in the Report fairly presents, in all material respects, the
financial condition and results of operations of the Company.
Date: March 11, 2011
| /s/ Martin McGlynn | ||||
| Martin McGlynn | ||||
| President and Chief Executive Officer | ||||
CONFIDENTIAL